India Nuclear Medicine Market Size & Outlook, 2026-2033
Global Market
Related Markets
India nuclear medicine market highlights
- The India nuclear medicine market generated a revenue of USD 639.4 million in 2025 and is expected to reach USD 1,211.0 million by 2033.
- The India market is expected to grow at a CAGR of 7.5% from 2026 to 2033.
- In terms of segment, diagnostics was the largest revenue generating product in 2025.
- Diagnostics is the most lucrative product segment registering the fastest growth during the forecast period.
Nuclear medicine market data book summary
| Market revenue in 2025 | USD 639.4 million |
| Market revenue in 2033 | USD 1,211.0 million |
| Growth rate | 7.5% (CAGR from 2026 to 2033) |
| Largest segment | Diagnostics |
| Fastest growing segment | Diagnostics |
| Historical data | 2021 - 2024 |
| Base year | 2025 |
| Forecast period | 2026 - 2033 |
| Quantitative units | Revenue in USD million |
| Market segmentation | Diagnostics, Therapeutics |
| Key market players worldwide | GE HealthCare Technologies Inc Common Stock, Jubilant Pharmova, Nordion, Bracco, Iren SpA, Abliva AB, Lantheus Holdings Inc, Eckert & Ziegler Bebig SA, Mallinckrodt PLC Ordinary Shares - New, Cardinal Health Inc |
Other key industry trends
- In terms of revenue, India accounted for 3.0% of the global nuclear medicine market in 2025.
- Country-wise, U.S. is expected to lead the global market in terms of revenue in 2033.
- In Asia Pacific, China nuclear medicine market is projected to lead the regional market in terms of revenue in 2033.
- China is the fastest growing regional market in Asia Pacific and is projected to reach USD 1,880.0 million by 2033.
The nuclear medicine market in India is expected to grow at a significant rate during the forecast period. The country has facilities to introduce larger number of radioisotopes for the treatment of cancer. For instance, in 2019, the country’s biggest cyclotron facility, Cyclone-30, started operating in Kolkata and exporting Germanium-68 and Palladium-103 worldwide.
Toshiba Medical Systems operating through Erbis Engineering; and Mallinckrodt, Inc. operating through Tyco Healthcare India Pvt. Ltd. supply radioisotopes in the country. It has been observed that PET scans are mostly used in the diagnosis of cancer and cardiac & urological diseases, while SPECT scans are mainly used in cardiology, as well as in oncology and general diagnostic procedures.
There are more than 200 PET-CT scans in India. Governments of various states, such as Gujarat, Jammu & Kashmir, and Punjab, are also procuring PET and SPECT scanners to increase access to nuclear diagnostic procedures. These states are subsidizing the cost of radioisotopes and are expected to provide tax benefits to companies that are looking to set up nuclear pharmacies in the country.
No credit card required*
Publish Date: Jun 17, 2026
Horizon in a snapshot
- 30K+ Global Market Reports
- 120K+ Country Reports
- 1.2M+ Market Statistics
- 200K+ Company Profiles
- Industry insights and more
Three ways to get this data
Subscribe to the databook, customize it, or ask a question.Horizon Databook
Unlock every chart on this page and get dashboard access
- Statistics1.2M+ across all markets
- Databooks30K+ global, 120K+ country
- Companies200K+ profiles
- ExportPDF, Dashboard, XLS & PNG, licensed to cite
Customize it
Customize data as per your requirement
- AddCountries, segments, years
- RecutTo your product definition
- ExtendCompany-level detail
- OrA bespoke databook
- Turnaround5–10 working days
Ask Prism AI
A cited answer in seconds
- Corpus30,000 studies, 1.2M points
- ScopeAll markets, not just this
- CitationTraced to report & table
- HonestySays "not covered" if so
- SpeedSeconds, not days
Nuclear Medicine Market Scope
Nuclear Medicine Market Companies
| Name | Profile | # Employees | HQ | Website |
|---|---|---|---|---|
| GE HealthCare Technologies Inc Common Stock | View profile | 51,000 | 500 West Monroe Street, Chicago, IL, United States, 60661 | www.gehealthcare.com |
| Cardinal Health Inc | View profile | 48,000 | 7000 Cardinal Place, Dublin, OH, United States, 43017 | www.cardinalhealth.com |
| Mallinckrodt PLC Ordinary Shares - New | View profile | 2,700 | College Business and Technology Park, Cruiserath, Blanchardstown, Dublin, Ireland, 15 | www.mallinckrodt.com |
| Eckert & Ziegler Bebig SA | View profile | 501-1000 | Seneffe, Hainaut, Belgium, Europe | www.ezag.com/home/ |
| Nordion | View profile | 251-500 | Kanata, Ontario, Canada, North America | nordion.com |
| Bracco | View profile | 1001-5000 | Milan, Lombardia, Italy, Europe | www.bracco.com |
| Lantheus Holdings Inc | View profile | 834 | 201 Burlington Road, South Building, Bedford, MA, United States, 01730 | www.lantheus.com |
| Jubilant Pharmova | View profile | 10001+ | Noida, Uttar Pradesh, India, Asia | www.jubilantpharmova.com |
| Iren SpA | View profile | 10,000 | Via Nubi di Magellano, 30, Reggio Emilia, Italy, 42123 | www.gruppoiren.it |
| Abliva AB | View profile | 6 | Scheeletorget 1, Medicon Village, Lund, Sweden, 223 81 | www.abliva.com |
India Nuclear Medicine Market Outlook
The databook is designed to serve as a comprehensive guide to navigating this sector. The databook focuses on market statistics denoted in the form of revenue and y-o-y growth and CAGR across the globe and regions. A detailed competitive and opportunity analyses related to Nuclear Medicine Market Outlook will help companies and investors design strategic landscapes.
Diagnostics was the largest segment with a revenue share of 87.93% in 2025.
Horizon Databook has segmented the India nuclear medicine market based on diagnostics, therapeutics covering the revenue growth of each sub-segment from 2021 to 2033.
The nuclear medicine market in India is expected to grow at a significant rate during the forecast period. The country has facilities to introduce larger number of radioisotopes for the treatment of cancer. For instance, in 2019, the country’s biggest cyclotron facility, Cyclone-30, started operating in Kolkata and exporting Germanium-68 and Palladium-103 worldwide.
Toshiba Medical Systems operating through Erbis Engineering; and Mallinckrodt, Inc. operating through Tyco Healthcare India Pvt. Ltd. supply radioisotopes in the country. It has been observed that PET scans are mostly used in the diagnosis of cancer and cardiac & urological diseases, while SPECT scans are mainly used in cardiology, as well as in oncology and general diagnostic procedures.
There are more than 200 PET-CT scans in India. Governments of various states, such as Gujarat, Jammu & Kashmir, and Punjab, are also procuring PET and SPECT scanners to increase access to nuclear diagnostic procedures. These states are subsidizing the cost of radioisotopes and are expected to provide tax benefits to companies that are looking to set up nuclear pharmacies in the country.
- India Nuclear Medicine Market Product Outlook (Revenue, USD Million , 2021-2033)
- Diagnostics
- Therapeutics
- India Nuclear Medicine Market Application Outlook (Revenue, USD Million , 2021-2033)
- Cardiology
- Neurology
- Oncology
- Thyroid
- Lymphoma
- Bone Metastasis
- Endocrine Tumor
- Pulmonary Scans
- Urology
- Other
- India Nuclear Medicine Market End Use Outlook (Revenue, USD Million , 2021-2033)
- Hospitals
- Diagnostic Centers
- Others
Reasons to subscribe to Nuclear Medicine Market Outlook databook
- Access to comprehensive data: Horizon Databook provides over 1 million market statistics and 20,000+ reports, offering extensive coverage across various industries and regions.
- Informed decision making: Subscribers gain insights into market trends, customer preferences, and competitor strategies, empowering informed business decisions.
- Cost-Effective solution: It's recognized as the world's most cost-effective market research database, offering high ROI through its vast repository of data and reports.
- Customizable reports: Tailored reports and analytics allow companies to drill down into specific markets, demographics, or product segments, adapting to unique business needs.
- Strategic advantage: By staying updated with the latest market intelligence, companies can stay ahead of competitors, anticipate industry shifts, and capitalize on emerging opportunities.
Target buyers of Nuclear Medicine Market Outlook databook
- Our clientele includes a mix of Nuclear Medicine Market Outlook companies, investment firms, advisory firms & academic institutions.
- 30% of our revenue is generated working with investment firms and helping them identify viable opportunity areas.
- Approximately 65% of our revenue is generated working with competitive intelligence & market intelligence teams of market participants (manufacturers, service providers, etc.).
- The rest of the revenue is generated working with academic and research not-for-profit institutes. We do our bit of pro-bono by working with these institutions at subsidized rates.
Horizon Databook provides a detailed overview of country-level data and insights on the India Nuclear Medicine Market Outlook, including forecasts for subscribers. This country databook contains high-level insights into India Nuclear Medicine Market Outlook from 2021 to 2033, including revenue numbers, major trends, and company profiles.
India Nuclear Medicine Market, 2021-2033 (US$M)
India nuclear medicine market statistics, by product, 2021-2033 (US$M)
